In this article, Gustaf Duhs, Partner and Head of Competition and Regulatory Law at Stevens & Bolton LLP, sets out a brief summary of the recent case before the CJEU relating to fixed pharmacy prices involving online pharmacy DocMorris and what this ruling means for the online sale of pharmaceuticals in Europe; further, Gustaf considers the latest developments in Germany and more generally in the EU following the CJEU’s decision on the matter.